Lantus (insulin glargine) is a prescription drug that’s used to manage blood sugar levels in people with diabetes. Lantus’s cost may depend on your dosage, whether you have health insurance, and the ...
The world's three premier makers of insulin are reducing prices like never before. In a span of less than three weeks, Eli Lilly, Novo Nordisk and Sanofi—in that order—have announced price cuts to ...
Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...
On the heels of Viatris and Biocon Biologics’ landmark diabetes copycat Semglee, another interchangeable biosimilar is crashing the infamously pricey insulin market. Wednesday, the FDA blessed Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results